A double-blind, placebo-controlled review employed intravenous allogeneic human MSCs in 53 submit-MI sufferers, with identical adverse activities concerning the two groups. Ambulatory EKG confirmed decreased episodes of ventricular tachycardia, as well as enhanced compelled expiratory volume in a single 2nd on pulmonary perform tests from the team